Company Profile

Lamprogen Inc
Profile last edited on: 1/31/18      CAGE: 6R8V5      UEI: K25TMBQBHAQ5

Business Identifier: Polymeric nanoparticles and microfluidic technology,
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7009 40th Avenue North East
Seattle, WA 98115
   (206) 524-2330
Location: Single
Congr. District: 07
County: King

Public Profile

Lamprogen Inc is a biomedical spin-out from a University of Washington chemistry lab run by Dr. Daniel Chiu. The company, foudned by Chiu and employing University of Washington researchers, focuses on the development of polymeric nanoparticles and microfluidic technology, particularly fluorescent particles and digital polymerase chain reactions (dPCR). These technologies have applications in medical research and biomedical imaging.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $149,800
Project Title: Pdot Enabled Cyclic Imaging Cytometry
2020 2 NIH $1,549,882
Project Title: Ultra-Bright Fluorescent Probes for Flow Cytometry
2018 2 NIH $1,144,304
Project Title: Self-Digitization Microfluidic Platform for Digital PCR
2017 2 NIH $1,129,272
Project Title: Semiconducting Polymer Dots for Multiplexed Assays
2014 1 NSF $150,000
Project Title: Developing Low-Cost Instrumentation for Self-Digitization-Based Digital PCR

Key People / Management

  Daniel Chiu -- Founder

  Jason Eugene Kreutz -- Director of Microtechnology

  Jiangbo Yu -- Director of Polymer Chemistry

  Xing-Hua Zhou -- Senior Scientist